Cargando…

Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications

Cell cycle deregulation is common in human hepatocellular carcinoma (HCC). To ensure proper cell cycle controlling, cyclin/cyclin-dependent kinases (CDK) complexes are tightly regulated by CDK inhibitors (CKIs) in normal cells. However, insufficient cyclin-dependent kinase inhibitor 1B (CDKN1B, also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yu-Ting, Wu, Wen-Ren, Chen, Lih-Ren, Kuo, Kung-Kai, Tsai, Cheng-Hui, Huang, Yu-Ting, Lan, Yu-Hsuan, Chang, Fang-Rong, Wu, Yang-Chang, Shiue, Yow-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598353/ https://www.ncbi.nlm.nih.gov/pubmed/28962365 http://dx.doi.org/10.1016/j.toxrep.2015.01.010

Ejemplares similares

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

Deficiency of the Cyclin-Dependent Kinase Inhibitor, CDKN1B, Results in Overgrowth and Neurodevelopmental Delay
por: Grey, William, et al.
Publicado: (2013)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas
por: Liu, Weidong, et al.
Publicado: (2011)

Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma
por: Li, Bei, et al.
Publicado: (2020)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

Mitotic p21(Cip1/CDKN1A) is regulated by cyclin-dependent kinase 1 phosphorylation
por: Kreis, Nina-Naomi, et al.
Publicado: (2016)

Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A
por: Wu, Bing-Hao, et al.
Publicado: (2016)

Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer
por: Wu, Ziyu, et al.
Publicado: (2015)

Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
por: Rathi, Sonika, et al.
Publicado: (2020)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

MAF1 represses CDKN1A through a Pol III-dependent mechanism
por: Lee, Yu-Ling, et al.
Publicado: (2015)

Tbx2 Controls Lung Growth by Direct Repression of the Cell Cycle Inhibitor Genes Cdkn1a and Cdkn1b
por: Lüdtke, Timo H-W., et al.
Publicado: (2013)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Arya, Ashutosh Kumar, et al.
Publicado: (2017)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

Evolution of the CDKN1C-KCNQ1 imprinted domain
por: Ager, Eleanor I, et al.
Publicado: (2008)

Cyclin Kinase-independent role of p21(CDKN1A) in the promotion of nascent DNA elongation in unstressed cells
por: Mansilla, Sabrina F, et al.
Publicado: (2016)

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

CDKN1A upregulation and cisplatin-pemetrexed resistance in non-small cell lung cancer cells
por: Zamagni, Alice, et al.
Publicado: (2020)

Natural compound library screening identifies Sanguinarine chloride for the treatment of SCLC by upregulating CDKN1A
por: Zhong, Mingtian, et al.
Publicado: (2022)

Upregulation of MicroRNA-15a Contributes to Pathogenesis of Abdominal Aortic Aneurysm (AAA) by Modulating the Expression of Cyclin-Dependent Kinase Inhibitor 2B (CDKN2B)
por: Gao, Peng, et al.
Publicado: (2017)

Epigenetic Characterization of CDKN1C in Placenta Samples from Non-syndromic Intrauterine Growth Restriction
por: López-Abad, Miriam, et al.
Publicado: (2016)

The association of CDKN2BAS gene polymorphisms and intracranial aneurysm: A meta-analysis
por: Yu, Ting, et al.
Publicado: (2020)

CDKN2AIP is critical for spermiogenesis and germ cell development
por: Cao, Yuming, et al.
Publicado: (2022)

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
por: Minarikova, Petra, et al.
Publicado: (2016)

Effects of CDKN2B‐AS1 polymorphisms on the susceptibility to coronary heart disease
por: Huang, Kang, et al.
Publicado: (2019)

Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx
por: Chernock, Rebecca D., et al.
Publicado: (2012)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
por: Waheed, Sana, et al.
Publicado: (2019)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer
por: Sasiadek, M M, et al.
Publicado: (2004)

CDKN1A: A double-edged sword in fatty liver?
por: Valenti, Luca, et al.
Publicado: (2014)

Analysis of CDKN1C in fetal growth restriction and pregnancy loss
por: Suntharalingham, Jenifer P., et al.
Publicado: (2020)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter
por: Ou, Minghui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6oalc1c449c7g4bk6g68r5kfsr